Velaglucerase Alfa
CAS 884604-91-5 2 FDA-DMF suppliersBiologic
Overview
Velaglucerase alfa is an enzyme replacement therapy used for the treatment of Gaucher's disease, a condition where fatty substances accumulate in certain organs. It acts by replacing the deficient glucocerebrosidase enzyme, helping to break down accumulated lipids in patients.
Therapeutic areas
Gaucher Disease
Related APIs
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.